27848974|t|Differential expression of TGF-β superfamily members and role of Smad1 / 5 / 9 - signalling in chondral versus endochondral chondrocyte differentiation
27848974|a|Proteins of the transforming-growth-factor-β (TGF-β)- superfamily have a remarkable ability to induce cartilage and bone and the crosstalk of TGF-β - and BMP-signalling pathways appears crucial during chondrocyte development. Aim was to assess the regulation of TGF-β - superfamily members and of Smad2 / 3 - and Smad1 / 5 / 9 - signalling during endochondral in vitro chondrogenesis of mesenchymal stromal cells (MSC) relative to chondral redifferentiation of articular chondrocytes (AC) to adjust chondrocyte development of MSC towards a less hypertrophic phenotype. While MSC increased BMP4 and BMP7 and reduced TGFBR2 and TGFBR3 - expression during chondrogenesis, an opposite regulation was observed during AC - redifferentiation. Antagonists CHRD and CHL2 rose significantly only in AC - cultures. AC showed higher initial BMP4, pSmad1 / 5 / 9 and SOX9 protein levels, a faster (re-)differentiation but a similar decline of pSmad2 / 3 - and pSmad1 / 5 / 9 - signalling versus MSC - cultures. BMP-4 / 7 - stimulation of MSC -pellets enhanced SOX9 and accelerated ALP - induction but did not shift differentiation towards osteogenesis. Inhibition of BMP-signalling by dorsomorphin significantly reduced SOX9, raised RUNX2, maintained collagen-type-II and collagen-type-X lower and kept ALP-activity at levels reached at initiation of treatment. Conclusively, ALK1 ,2,3,6- signalling was essential for MSC - chondrogenesis and its prochondrogenic rather than prohypertrophic role may explain why inhibition of canonical BMP-signalling could not uncouple cartilage matrix production from hypertrophy as this was achieved with pulsed PTHrP -application.
27848974	13	23	expression	T038	UMLS:C1171362
27848974	27	32	TGF-β	T103	UMLS:C0040690
27848974	65	70	Smad1	T103	UMLS:C1566789
27848974	73	74	5	T103	UMLS:C0529859
27848974	77	78	9	T103	UMLS:C1566814
27848974	81	91	signalling	T038	UMLS:C3537152
27848974	95	103	chondral	T082	UMLS:C0442012
27848974	124	151	chondrocyte differentiation	T038	UMLS:C1817330
27848974	152	160	Proteins	T103	UMLS:C0033684
27848974	168	196	transforming-growth-factor-β	T103	UMLS:C0040690
27848974	198	203	TGF-β	T103	UMLS:C0040690
27848974	254	263	cartilage	T017	UMLS:C0007301
27848974	268	272	bone	T017	UMLS:C0262950
27848974	294	299	TGF-β	T103	UMLS:C0040690
27848974	306	329	BMP-signalling pathways	T038	UMLS:C1155364
27848974	353	376	chondrocyte development	T038	UMLS:C1817331
27848974	400	410	regulation	T038	UMLS:C1327622
27848974	414	419	TGF-β	T103	UMLS:C0040690
27848974	449	454	Smad2	T103	UMLS:C0528860
27848974	457	458	3	T103	UMLS:C0529120
27848974	465	470	Smad1	T103	UMLS:C1566789
27848974	473	474	5	T103	UMLS:C0529859
27848974	477	478	9	T103	UMLS:C1566814
27848974	481	491	signalling	T038	UMLS:C3537152
27848974	521	535	chondrogenesis	T038	UMLS:C0598067
27848974	539	564	mesenchymal stromal cells	T017	UMLS:C3178844
27848974	566	569	MSC	T017	UMLS:C3178844
27848974	583	591	chondral	T082	UMLS:C0442012
27848974	613	622	articular	T082	UMLS:C0022417
27848974	623	635	chondrocytes	T017	UMLS:C0225369
27848974	637	639	AC	T017	UMLS:C0225369
27848974	651	674	chondrocyte development	T038	UMLS:C1817331
27848974	678	681	MSC	T017	UMLS:C3178844
27848974	697	709	hypertrophic	T038	UMLS:C0020564
27848974	727	730	MSC	T017	UMLS:C3178844
27848974	741	745	BMP4	T103	UMLS:C0530979
27848974	750	754	BMP7	T103	UMLS:C0083867
27848974	767	773	TGFBR2	T103	UMLS:C1506219
27848974	778	784	TGFBR3	T103	UMLS:C1700222
27848974	787	797	expression	T038	UMLS:C1171362
27848974	805	819	chondrogenesis	T038	UMLS:C0598067
27848974	833	843	regulation	T038	UMLS:C1327622
27848974	864	866	AC	T017	UMLS:C0225369
27848974	869	886	redifferentiation	T038	UMLS:C0007613
27848974	888	899	Antagonists	T103	UMLS:C0243076
27848974	900	904	CHRD	T103	UMLS:C1436410
27848974	909	913	CHL2	T103	UMLS:C1454907
27848974	941	943	AC	T017	UMLS:C0225369
27848974	946	954	cultures	T058	UMLS:C0007585
27848974	956	958	AC	T017	UMLS:C0225369
27848974	981	985	BMP4	T103	UMLS:C0530979
27848974	987	993	pSmad1	T103	UMLS:C1566789
27848974	996	997	5	T103	UMLS:C0529859
27848974	1000	1001	9	T103	UMLS:C1566814
27848974	1006	1010	SOX9	T103	UMLS:C1569839
27848974	1011	1025	protein levels	T033	UMLS:C0428479
27848974	1036	1056	(re-)differentiation	T038	UMLS:C0007613
27848974	1082	1088	pSmad2	T103	UMLS:C0528860
27848974	1091	1092	3	T103	UMLS:C0529120
27848974	1099	1105	pSmad1	T103	UMLS:C1566789
27848974	1108	1109	5	T103	UMLS:C0529859
27848974	1112	1113	9	T103	UMLS:C1566814
27848974	1116	1126	signalling	T038	UMLS:C3537152
27848974	1134	1137	MSC	T017	UMLS:C3178844
27848974	1140	1148	cultures	T058	UMLS:C0007585
27848974	1150	1155	BMP-4	T103	UMLS:C0530979
27848974	1158	1159	7	T103	UMLS:C0083867
27848974	1177	1180	MSC	T017	UMLS:C3178844
27848974	1199	1203	SOX9	T103	UMLS:C1569839
27848974	1220	1223	ALP	T103	UMLS:C0002059
27848974	1226	1235	induction	T038	UMLS:C0014431
27848974	1278	1290	osteogenesis	T038	UMLS:C0029433
27848974	1306	1320	BMP-signalling	T038	UMLS:C1155364
27848974	1324	1336	dorsomorphin	T103	UMLS:C1871460
27848974	1359	1363	SOX9	T103	UMLS:C1569839
27848974	1372	1377	RUNX2	T103	UMLS:C1529564
27848974	1390	1406	collagen-type-II	T103	UMLS:C0009331
27848974	1411	1426	collagen-type-X	T103	UMLS:C0009339
27848974	1442	1454	ALP-activity	T038	UMLS:C1149888
27848974	1515	1519	ALK1	T103	UMLS:C1504731
27848974	1528	1538	signalling	T038	UMLS:C3537152
27848974	1557	1560	MSC	T017	UMLS:C3178844
27848974	1563	1577	chondrogenesis	T038	UMLS:C0598067
27848974	1586	1601	prochondrogenic	T033	UMLS:C0243095
27848974	1614	1629	prohypertrophic	T033	UMLS:C0243095
27848974	1675	1689	BMP-signalling	T038	UMLS:C1155364
27848974	1709	1725	cartilage matrix	T103	UMLS:C0054832
27848974	1742	1753	hypertrophy	T038	UMLS:C0020564
27848974	1787	1792	PTHrP	T103	UMLS:C0070099